Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report

医学 贫血 血液透析 血红蛋白 红细胞生成 透析 不利影响 内科学 外科 胃肠病学
作者
Cai Xu,Deng-Gui Luo,Zhe-Yan Liu,Dong Ho Yang,Dandan Wang,Yuan-Zhao Xu,Jun Jie Yang,Bo Fu,Airong Qi
出处
期刊:World Journal of Clinical Cases [Baishideng Publishing Group]
卷期号:10 (35): 13122-13128
标识
DOI:10.12998/wjcc.v10.i35.13122
摘要

BACKGROUND: Hypoxia-inducible factor prolyl hydroxylase inhibitor is a new class of drugs for treating renal anemia. It is a second-generation hypoxia-inducible factor prolyl hydroxylase-2 (PHD2) inhibitor. Roxadustat can effectively increase hemoglobin in patients with dialysis-dependent chronic kidney disease, with an adverse events profile comparable to that of epoetin alfa. We administered roxadustat to a maintenance hemodialysis patient who was allergic to erythropoiesis-stimulating agents (ESAs) and depended on blood transfusion for five years. After applying Roxadustat, the patient's anemia improved significantly. CASE SUMMARY: A 77-year-old Chinese man had type 2 diabetes for 16 years, underwent maintenance hemodialysis for five years, and had fatigue for five years. Laboratory tests showed severe anemia (hemoglobin concentration of 42 g/L). The patient was administered a subcutaneous injection of ESAs before dialysis. He suffered an allergic shock immediately and fainted. His blood pressure dropped to undetectable levels. He was not administered ESAs henceforth. The patient was prescribed iron supplements and received blood transfusions occasionally for five years. His hemoglobin concentration ranged from 42-68 g/L. After taking six weeks of oral roxadustat three times weekly (100 mg TIW), the patient's hemoglobin concentration increased significantly, and his symptoms decreased. We adjusted the doses of roxadustat, and the hemoglobin concentration was maintained between 97 and 126 g/L. CONCLUSION: Oral roxadustat is effective in treating anemia in maintenance hemodialysis patients who cannot be administered ESAs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ylva完成签到,获得积分10
刚刚
plemon完成签到,获得积分10
1秒前
圆圆完成签到,获得积分10
1秒前
unqiue的应助被荼蘼采纳,获得10
1秒前
元吉的应助被荼蘼采纳,获得10
1秒前
Ximilu发布了新的文献求助10
1秒前
我是老大的应助被荼蘼采纳,获得10
1秒前
heady发布了新的文献求助10
1秒前
明理的千筹发布了新的文献求助100
1秒前
无极微光的应助被酷爱小飞采纳,获得20
2秒前
Akim的应助被凌风采纳,获得10
2秒前
Cecilia发布了新的文献求助10
2秒前
林自完成签到,获得积分10
2秒前
朴实云朵完成签到,获得积分10
3秒前
齐齐发布了新的文献求助10
3秒前
Nice发布了新的文献求助10
3秒前
3秒前
kevinjedi完成签到 ,获得积分10
3秒前
yookia完成签到,获得积分0
4秒前
慕1完成签到,获得积分10
4秒前
Sixy_完成签到,获得积分10
4秒前
4秒前
韩邹光完成签到,获得积分10
4秒前
方方发布了新的文献求助10
4秒前
研友_599Y85完成签到,获得积分10
4秒前
团子完成签到,获得积分10
5秒前
dreamdraver完成签到,获得积分10
5秒前
慕青的应助被panpan采纳,获得10
5秒前
5秒前
水知寒完成签到,获得积分0
5秒前
柳亦诚发布了新的文献求助10
6秒前
molihuakai的应助被李佳佳采纳,获得10
7秒前
怕黑的缘分的应助被stone采纳,获得10
7秒前
余香的应助被saflgf采纳,获得10
7秒前
8秒前
粽粽发布了新的文献求助10
8秒前
侯_发布了新的文献求助30
8秒前
饼饼发布了新的文献求助10
9秒前
jiangjiang完成签到,获得积分10
9秒前
ylva发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346